Skip to main
ALC

ALC Stock Forecast & Price Target

ALC Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 18%
Buy 36%
Hold 36%
Sell 9%
Strong Sell 0%

Bulls say

Alcon is a global leader in the visioncare industry, with a strong portfolio of products that include contact lenses, lenscare solutions, and a wide range of ocular health products. The company's recent spin-off from Novartis provides a lucrative opportunity to investors as Alcon continues to launch innovative products in high-growth categories. Combined with solid operating margin improvement and a strong product pipeline, we believe Alcon is well positioned for sustained mid-single digit revenue growth and double-digit EPS growth.

Bears say

Alcon is currently experiencing some challenges, as their top-line growth projections are lower than what was expected. Although the company is making strides in the surgical segment, they face tough competition and challenges in the contact lens market. Additionally, there are concerns about the impact of tariffs and potential refunds on their financials. However, the company has a strong installed base and is making strategic moves, which may drive growth and margin improvements in the future.

ALC has been analyzed by 11 analysts, with a consensus rating of Buy. 18% of analysts recommend a Strong Buy, 36% recommend Buy, 36% suggest Holding, 9% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Alcon Inc. - Registered Shares and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Alcon Inc. - Registered Shares (ALC) Forecast

Analysts have given ALC a Buy based on their latest research and market trends.

According to 11 analysts, ALC has a Buy consensus rating as of May 15, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $83.78, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $83.78, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Alcon Inc. - Registered Shares (ALC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.